Corneal tissue levels of topically applied ofloxacin
- 1 July 1997
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Cataract & Refractive Surgery
- Vol. 23 (6) , 898-902
- https://doi.org/10.1016/s0886-3350(97)80251-9
Abstract
Purpose: To evaluate the levels of ofloxacin (Ocuflox®) in human corneal tissue in patients exposed to various dosing regimens and application methods. Setting: Corneal Consultants of Indiana, Indianapolis, Indiana, USA. Methods: Forty patients meeting inclusion criteria were recruited from persons scheduled to have penetrating keratoplasty (PKP). Patients were placed into one of two study groups of 20 each based on dosing regimen and application method. The SAS GLM (General Linear Models) procedure was used to test for differences in mean Ocuflox tissue concentration among study groups and for interaction effects of preoperative diagnosis, trephine size, dosing regimen, and corneal integrity. Results: Corneal tissue concentrations of Ocuflox were elevated significantly by varying drug application methods and dosing schedules before PKP. Eyes receiving medication every 15 minutes for 4 hours had significantly higher levels of Ocuflox than those receiving the drug in six doses over 24 hours before surgery. Ocuflox concentrations exceeded the MIC90 (minimum inhibitory concentration) for key ocular pathogens in essentially all cornea specimens studied. Conclusion: Ocuflox penetration was improved by administering it in a controlled setting at 15 minute intervals over 4 hours. The drug provided high tissue levels in both the cornea and aqueous humor, which together with its broad range of antibacterial coverage, should make it a good choice for prophylactic treatment.Keywords
This publication has 16 references indexed in Scilit:
- Comparative tear concentrations over time of ofloxacin and tobramycin in human eyesClinical Pharmacology & Therapeutics, 1994
- In-vitro activities of quinolones against mycobacteriaJournal of Antimicrobial Chemotherapy, 1993
- Ofloxacin in Human Serum, Urine, and Tear Film After Topical ApplicationCornea, 1992
- Review of Preclinical Studies with OfloxacinClinical Infectious Diseases, 1992
- Therapy with Newer Oral -Lactam and Quinolone Agents for Infections of the Skin and Skin Structures: A ReviewClinical Infectious Diseases, 1992
- Ofloxacin Clinical PharmacokineticsClinical Pharmacokinetics, 1992
- Ofloxacin compared with chloramphenicol in the management of external ocular infection.British Journal of Ophthalmology, 1991
- OfloxacinDrugs, 1991
- The clinical experience with ofloxacin in the treatment of sexually transmitted diseasesAmerican Journal of Obstetrics and Gynecology, 1991
- The Comparative In Vitro Activity of Ofloxacin and Selected Ophthalmic Antimicrobial Agents Against Ocular Bacterial IsolatesAmerican Journal of Ophthalmology, 1989